Regulating Health AI for Better Patient Outcomes

A discussion led by Stanford HAI Associate Director Curt Langlotz highlights the challenges and opportunities in regulating AI in healthcare. The workshop, involving over 50 stakeholders, addressed gaps in current AI regulations, the need for better data transparency, and the potential benefits of AI tools that improve clinical efficiency. It emphasized shifting from pre-market to post-market surveillance to ensure patient safety and effective use of AI in clinical settings. The conversation also focused on aligning AI applications with user needs, such as automating documentation and enhancing patient engagement.